Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 35.89B | 34.18B | 31.21B | 29.52B | 26.95B | 27.34B |
Gross Profit | 26.41B | 24.93B | 22.53B | 21.48B | 19.73B | 19.45B |
EBITDA | 11.14B | 6.47B | 7.16B | 6.32B | 10.33B | 9.41B |
Net Income | 6.54B | 3.12B | 6.14B | 2.28B | 5.26B | 5.14B |
Balance Sheet | ||||||
Total Assets | 68.40B | 74.12B | 68.33B | 72.16B | 71.17B | 58.46B |
Cash, Cash Equivalents and Short-Term Investments | 10.18B | 11.24B | 11.28B | 9.70B | 11.66B | 6.95B |
Total Debt | 8.75B | 10.65B | 8.79B | 13.09B | 15.14B | 15.46B |
Total Liabilities | 27.00B | 28.31B | 24.93B | 29.31B | 29.65B | 28.54B |
Stockholders Equity | 41.00B | 45.44B | 43.16B | 40.19B | 38.85B | 29.72B |
Cash Flow | ||||||
Free Cash Flow | 6.46B | 4.42B | 5.55B | 4.77B | 5.42B | 6.38B |
Operating Cash Flow | 7.25B | 5.22B | 6.33B | 5.65B | 6.22B | 7.19B |
Investing Cash Flow | -449.00M | -667.00M | 906.00M | 667.00M | -3.06B | -2.99B |
Financing Cash Flow | -6.35B | -3.40B | -7.73B | -6.34B | -56.00M | -4.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | €1.43B | 11.20 | 179.08% | ― | 9.74% | 26.28% | |
73 Outperform | €15.28B | 81.16 | 23.55% | 0.40% | 25.33% | 6.58% | |
70 Outperform | €287.87B | 43.98 | 15.83% | 0.92% | 10.29% | 159.53% | |
69 Neutral | €1.80B | 39.08 | 64.04% | 1.87% | 10.61% | 12.63% | |
58 Neutral | €863.49M | 28.71 | 35.14% | 3.63% | -16.41% | -1.83% | |
50 Neutral | C$3.26B | 5.36 | -49.37% | 9.08% | 2.10% | -13.02% |